Molecular biologist of the University of Vienna establishes "Chemical Genetics" approach to regulate the activity of plant hormones

The plant researcher Tobias Sieberer of the Max F. Perutz Laboratories of the University of Vienna works on signal transduction of hormones, the so-called strigolactones. Within his search for chemical substances to influence the activity of this pathway, he will establish a high-throughput approach to test thousands of different chemical compounds. The project is funded by the Vienna Science and Technology Fund (WWTF).

Strigolactones are plant hormones, which were first discovered in crop plants during the infection with the parasitic plant "Striga". Only plants which produce strigolactones were infected with the parasite resulting in a significant reduction of vigour. Moreover, this signalling pathway plays also an important role in plants to initiate symbiotic interactions with mycorrhiza fungi to enhance the absorption of nutrients from the soil. The third hormonal effect known so far is an influence on shoot branching. If strigolactones are inactivated in experiments, the number of branches is increased. A means to manipulate these three known hormonal effects would have a strong potential for agricultural applications. Particularly in countries with food shortage parasite infection might be diminished. Moreover the rate of shoot branching is an important breeding trait, which affects the quantity and quality of crop harvest as well as the technical effort in cultivation techniques.

Searching for a substance with specific effect
"We want to find substances, which block or stimulate strigolactone effects to use it for different purposes", Tobias Sieberer describes the interdisciplinary project funded by the WWTF. Sieberer and his project partners Gang Dong of the Max F. Perutz Laboratories and Gerhard Ecker of the Department for Medical Chemistry of the University of Vienna selected an innovative approach as yet not well established in academic research in Austria: Virtual and real high-throughput screening of a vast number of known small molecules. Gang Dong is a structural biologist and will reveal the 3D structure of known enzymes of the strigolatone biosynthesis pathway. The protein structures will then be compared to 3D structures of known small molecules in Gerhard Ecker’s virtual database. With this narrowed selection of inhibitor candidates functional experiments are carried out in the model plant Arabidopsis thaliana.

A second more unbiased approach is searching for substances with the direct help of the Arabidopsis plant. “The project allows the purchase of a highly diverse compound library containing over 30.000 molecule classes. We will grow the plants on one of the chemicals each under controlled laboratory conditions", explains the plant researcher. The lab strain of Arabidopsis comprises a reporter gene, which is turned on if the applied substance alters strigolactone levels – the plant starts to fluoresce.

Bacterium helps plant researchers
Also the bacterium Escherichia coli is utilized for the search of strigolactone regulators. An engineered laboratory strain produces beta-carotene, the dye also found in carrots, and thus colonies have an orange colour. With the help of molecular biological methods the researchers bring the proteins for strigolactone biosynthesis into the bacteria. If the proteins are active, the beta-carotene is recognized as substrate and will be degraded resulting in colourless bacterial colonies. Again the researchers then test for different chemical substances. Inhibitor molecules can easily be detected by the orange-coloured colonies as the degradation of beta-carotene is blocked and the dye will accumulate.

Results of the interdisciplinary project important for basic and applied research
The project allows the establishment of the first academic compound screening facility in Austria. In pharmaceutical companies such libraries are routinely used for drug discovery. For scientists from public research institutes the use of such libraries is cost-intensive and results are subjected to complicate patent laws. "Our library will be open for collaboration with interested scientists from the Viennese area", Sieberer illustrates the possibility to use this library for research on additional model organisms. Results of this chemical genetics technique will support basic and applied research. For the strigolactone project this means that discovered inhibitors might be used to enlighten the basic mechanisms of biosynthesis and signalling of the hormone. But also in applied research this might lead to the development of directed shoot branching regulation or impact on the infection rate of plant parasites.

Strengthen plant research in Vienna
Tobias Sieberer, born 1972 in Amstetten, studied Genetics at the University of Vienna and received his doctoral degree at the University of Natural Resources and Applied Life Sciences (BOKU) in 2003. With the support of an Erwin Schrödinger fellowship of the Austrian Science Fund (FWF) and an EMBO long-term Fellowship he spent a postdoctoral research period at the University of York in Great Britain. 2007 he returned as an independent group leader to the Max F. Perutz Laboratories in Vienna, where he is holding an APART fellowship of the Austrian Academy of Sciences. "Molecular plant science has a great tradition in the Anglo-Saxon area and the Benelux countries. To being able to strengthen plant science in Austria is an exciting possibility", Tobias Sieberer affirms the potential of Vienna as an international top location for his field. A very supportive role in his opinion has the positive funding opportunities in Austria, especially the WWTF. "With the WWTF, Vienna offers an highly attractive funding body that encourages to bridge basic and applied sciences". He would also appreciate long-term funding opportunities and particularly a tenure track system for young scientists in Austria who are establishing their independent, internationally competitive research group – like he is doing now.

The Max F. Perutz Laboratories are a joint-venture of the University of Vienna and the Medical University, founded 2005. This inter-university collaboration is a new and innovative approach to strengthen research and education at both universities. The 60 research groups at the institute in the Dr.-Bohr-Gasse work in the area of molecular cell biology. Since 2007 the Scientific Director of the institute is Graham Warren, a biochemist and former Yale-professor. www.mfpl.ac.at

Contact:
Dr. Tobias Sieberer
Max F. Perutz Laboratories
Department of Microbiology, Immunobiology
and Genetics, University of Vienna
1030 Vienna, Dr. Bohr-Gasse 9
T +43-1-4277-749 37
tobias.sieberer(at)univie.ac.at

Pamela Paulic
Communications
University of Vienna
1010 Wien, Dr.-Karl-Lueger-Ring 1
T +43-1-4277-175 31
pamela.paulic(at)univie.ac.at
www.univie.ac.at/175